® Consulta de Marcas Base do INPI · pesquisa e monitoramento

PIRCISLY

Registro de marca em vigor (Madri)

Marca Nominativa depositada no INPI em 09/03/2023 por Prometheus Biosciences, Inc., processo nº 501746197, nas classes 05, 42, 44. Registro em vigor até 09/03/2033.

Número do processo501746197
SituaçãoRegistro de marca em vigor (Madri)
ApresentaçãoNominativa
NaturezaMadri Produto/Serviço
Data do depósito09/03/2023
Data da concessão22/10/2024
Vigência até09/03/2033
TitularPrometheus Biosciences, Inc.
CNPJ/CPF do titular
UF · País— · US

Classes e especificação

Classe 05 — Farmacêuticos e saúde

Pharmaceutical preparations used for the treatment of gastrointestinal disorders and diseases, colitis, Crohn's disease, inflammatory bowel disease, systemic sclerosis, interstitial lung disease, systemic sclerosis-associated interstitial lung disease, arthritis, and other diseases of the immune, digestive, bowel, skin, joint, lung, liver, kidney, bile duct, or gastrointestinal systems, immune modulation and management of side effects associated with renal disorders and cancer; diagnostic preparations for clinical or medical laboratory use; diagnostic reagents for clinical or medical laboratory use.;

Classe 42 — Tecnologia e pesquisa

Medical laboratory services, namely, laboratory testing, medical diagnostic testing for research purposes, evaluation, and medical research services; medical laboratory services, namely, laboratory testing in the field of disease management and pathology and of patient diagnosis and patient selection.;

Classe 44 — Saúde e beleza

Disease management services; medical services, namely, providing medical information to health care providers, managed care providers and patients via computer networks; providing health information in the field of gastrointestinal diseases, colitis, Crohn's disease, inflammatory bowel disease, systemic sclerosis, interstitial lung disease, systemic sclerosis-associated interstitial lung disease, arthritis, and other diseases of the immune, digestive, bowel, skin, joint, lung, liver, kidney, bile duct, or gastrointestinal systems; providing information relating to medical diagnostic testing; providing information relating to treatment recommendation; medical consultation; providing information via a website about services for the diagnosis, prevention, and treatment of gastrointestinal disorders and diseases, colitis, Crohn's disease, inflammatory bowel disease, systemic sclerosis, interstitial lung disease, systemic sclerosis-associated interstitial lung disease, arthritis, and other diseases of the immune, digestive, bowel, skin, joint, lung, liver, kidney, bile duct, or gastrointestinal systems, immune modulation and management of side effects associated with renal disorders and cancer.;

Acompanhe este processo

Receba um e-mail a cada novo despacho publicado na RPI para o processo 501746197 — exigência, oposição, deferimento, prazo de pagamento — e quando alguém depositar uma marca parecida.

Monitorar esta marca Ver marcas parecidas

Andamento do processo no INPI

3 despacho(s) publicado(s) na Revista da Propriedade Industrial.

  1. 22/10/2024 Concessão de registro em designação código IPAS770 · RPI 2807
  2. 09/07/2024 Deferimento de designação código IPAS768 · RPI 2792
  3. 20/02/2024 Publicação de pedido de registro para oposição (exame formal de designação concluído) código IPAS756 · RPI 2772

Outras marcas de Prometheus Biosciences, Inc.